Wednesday, February 20, 2008 1:55:38 PM
IDM Pharma in Compliance With Nasdaq Requirements
February 20, 2008: 08:16 AM EST
NEW YORK (Associated Press) - Biopharmaceutical company IDM Pharma Inc. said Wednesday it regained compliance with the Nasdaq Stock Market by meeting minimum bid price requirements.
Nasdaq requires listed companies to maintain a closing bid price of at least $1 per share. On Feb. 19, the closing price of the company's common stock was $3.14 per share.
Earlier this month, the Nasdaq told IDM Pharma that its shares closed below the $1 threshold for the previous 30 days and warned it could be delisted.
http://money.cnn.com/news/newsfeeds/...d9123871db.htm
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM